Knowledge Exchange

2022 2021 2020 2019 2018 2017 2016
HKUMed finds risk of myocarditis in adolescents significantly reduced after receiving only one dose of Comirnaty; adolescents urged to get the first dose of COVID-19 vaccine
HKUMed finds risk of myocarditis in adolescents significantly reduced after receiving only one dose of Comirnaty; adolescents urged to get the first dose of COVID-19 vaccine

Click to view full text of Press Release

Media coverage:

The Standard Online

Date: January 25, 2022

Topic: Single BioNTech jab significantly reduces myocarditis risk for teens – HKU research

Link: https://bit.ly/3u7C3MS


RTHK Chinese Instant News

Date: January 25, 2022

Topic: 青少年延長至少三個月打第二針復必泰可降心肌炎機會

Link: https://bit.ly/3r2pG2D


RTHK Chinese Instant News

Date: January 25, 2022

Topic: 學者建議 12 歲或以上青少年盡快接種第一劑疫苗

Link: https://bit.ly/3G19dA5


CRHK Instant News

Date: January 25, 2022

Topic: 港大研究:青少年接種 2 劑復必泰後 患心肌炎風險較接種 1 劑高 6 倍

Link: https://bit.ly/3AOT4wV


Now TV News

Date: January 25, 2022

Topic: 港大:僅打一針復必泰可大幅降低青少年患心肌炎機會

Link: https://bit.ly/3G51r8j


Ming Pao Instant News

Date: January 25, 2022

Topic: 港大研究:12 歲以上青少年打兩針復必泰 患心肌炎風險為打一針 7 倍

Link: https://bit.ly/3KPezBY


on.cc Instant News

Date: January 25, 2022

Topic: 青少年接種復必泰後 3 周打第二針 患心肌炎風險增逾 7 倍

Link: https://bit.ly/3H502jj


HKEJ Instant News

Date: January 25, 2022

Topic: 港大:青少年打一針復必泰大幅減患心肌炎機會

Link: https://bit.ly/3G9KiKB


Wen Wei Po Instant News

Date: January 25, 2022

Topic: 【抗擊新冠肺炎】港大籲青少年首針後隔 3 個月再打

Link: https://bit.ly/3fXbMbY


am730 Instant News

Date: January 26, 2022

Topic: 青少年打復必泰二針 港大建議隔 3 個月

Link: https://bit.ly/3tXMXou


Sky Post Instant News

Date: January 25, 2022

Topic: 新冠疫苗|兒童染疫失嗅覺險釀火警 專家指勿輕視後遺症 籲快打針

Link: https://bit.ly/3r3ztWk


Sky Post Instant News

Date: January 26, 2022

Topic: 青少年推遲次針復必泰 降心肌炎風險

Link: https://bit.ly/3IMol6p


HK01

Date: January 25, 2022

Topic: 復必泰|港大:青少年打第一針 隔 3 個月打第二針可降心肌炎風險

Link: https://bit.ly/3u3SGZK


Topick.hket.com

Date: January 25, 2022

Topic: 【疫苗接種】港大研究發現青少年接種 2 劑復必泰患心肌炎風險較接種 1 劑高 6 倍 建議延長 3 個月後再打

Link: https://bit.ly/3IxxKhY


etnet

Date: January 25, 2022

Topic: 【新冠肺炎】研究:青少年接種1劑復必泰,患心肌炎風險較兩劑低

Link: https://bit.ly/3r1GtTF


Hkcna.hk

Date: January 25, 2022

Topic: 港大研究:僅打一針復必泰可降低青少年患心肌炎機會

Link: https://bit.ly/3HhSREw


Udn.com (Taiwan)

Date: January 26, 2022

Topic: 香港研究稱:青少年 2 劑 BNT 心肌炎風險較 1 劑高 6 倍

Link: https://bit.ly/3g12lZ1

Facing the dilemma between unmet needs and costly drugs: what are the strategic solutions for rare diseases?

Dr Shirley Li spoke as a panelist at the WHO webinar series on country pharmaceutical pricing policies and presented the “Global Access and Unmet Needs of Orphan Drugs” based on the team’s previous work published in Value in Health.

Click to view the full text of paper

HKUMed achieves a breakthrough in retinoblastoma treatment by a light-triggered drug release system
HKUMed achieves a breakthrough in retinoblastoma treatment by a light-triggered drug release system

Click to view full version (English)

Click to view full version (Chinese)

HKUMed develops inhaled dry powder formulation of broad-spectrum antiviral against COVID-19 and influenza

HKUMed develops inhaled dry powder formulation of broad-spectrum antiviral against COVID-19 and influenza

Click to view full version

HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target
HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target

Click to view full version

HKUMed takes leading role in the largest cohort study on global hip fracture burden
HKUMed takes leading role in the largest cohort study on global hip fracture burden
香港大學藥理及藥劑學系 -藥劑師疫苗接種培訓計劃

香港大學李嘉誠醫學院藥劑學系-藥劑師疫苗接種培訓計劃

 

東方日報:

藥劑師疫苗接種培訓

NOW新聞台

藥劑師疫苗接種培訓

香港電台

藥劑師疫苗接種培訓

HK Standard

藥劑師疫苗接種培訓

信報

藥劑師疫苗接種培訓

Dr. Ruby Hoo and her team discovers a novel therapeutic target of ischaemia stroke

HKUMed discovers a novel mediator of cerebral ischaemia injury and its underlying mechanism which can be a new therapeutic target for ischaemic stroke

A research team from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has discovered a new regulator of blood-brain barrier disruption in ischaemia stroke. The discovery provides insight into the new mechanism of blood-brain barrier disruption which allows the future development of effective pharmacological therapy for patients with ischemia stroke...

Click to view full version

Dr Jenny Lam and her team develops mRNA powder formulation for inhalation

HKU develops inhaled dry powder formulation of messenger RNA Opens up new possibilities for treating and preventing various lung diseases

Click to view full version